Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018222

Options or other derivatives

  • Director acquired 95,419 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bright Rex · Director

Table II: Derivative

5 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-09 Grant or award : show line 1 in the form Stock Options +15,994 $9.93 2024-12-29 15,994 15,994 D
2020-03-09 Grant or award : show line 2 in the form Stock Options +12,773 $8.04 2027-07-12 12,773 12,773 D
2020-03-09 Grant or award : show line 3 in the form Stock Options +14,778 $8.54 2028-05-08 14,778 14,778 D
2020-03-09 Grant or award : show line 4 in the form Stock Options +29,271 $4.50 2029-05-16 29,271 29,271 D
2020-03-09 Grant or award : show line 5 in the form Stock Options +22,603 $5.96 2030-02-27 22,603 22,603 D
Loading xslF345X03/doc4.xml…